NGS Banner
Contributors

Jacqueline Chan, Sabine Eckert, Lyudmila Georgieva and Graham Speight

 

Introduction

One of the challenges in cancer research is the high level of genetic complexity and tumour heterogeneity. Detailed information about the genetic profile of each individual tumour may help guide treatment strategies1 .

NGS has enabled the simultaneous study of multiple mutations in high-penetrance cancer predisposition genes. However, tissue biopsies are typically archived as formalin-fixed, paraffin embedded (FFPE) blocks which can significantly compromise the quality and amount of nucleic acids available for genomics research.

To overcome these issues, we have used the SureSeq™ FFPE DNA Repair Mix, in combination with a hybridisation-based NGS custom enrichment panel, the SureSeq Ovarian Cancer Panel (Table 1) to identify somatic variation in key DNA repair genes associated with ovarian cancer.

Table 1: Key ovarian cancer-related genes in the SureSeq Ovarian Cancer PanelTable 1: Key ovarian cancer-related genes in the SureSeq Ovarian Cancer Panel.

To evaluate the application of a hybridisation-based approach we:

  • Compared the uniformity of coverage between a PCR-based and a hybridisation-based enrichment approach for the analysis of BRCA1 and BRCA2 in solid tumour samplesa
  • Identified potentially damaging variants in TP53BRCA1 and BRCA2 genes from DNA extracted from FFPE blocks of type II epithelial ovarian cancer (EOC) samplesb.

Register with us to read the full article

Once you have registered with us for free you will be able to read all our supportive literature, video tutorials and webinars.

CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter